These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6486990)

  • 21. In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin.
    Casal M; Rodríguez F
    Tubercle; 1982 Jun; 63(2):125-7. PubMed ID: 7179478
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of infections caused by 'atypical' mycobacteria.
    Grange JM
    J Antimicrob Chemother; 1984 Apr; 13(4):308-10. PubMed ID: 6725182
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.
    Yew WW; Kwan SY; Ma WK; Lui KS; Aung MK
    Clin Ther; 1989; 11(6):775-85. PubMed ID: 2611821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amikacin treatment for Mycobacterium marinum infection.
    Arai H; Nakajima H; Naito S; Kaminaga Y; Nagai R
    J Dermatol; 1986 Oct; 13(5):385-9. PubMed ID: 3546444
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous infection with Mycobacterium gordonae.
    McIntyre P; Blacklock Z; McCormack JG
    J Infect; 1987 Jan; 14(1):71-8. PubMed ID: 2880916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of pulmonary infection due to Mycobacterium chelonae: case report and review.
    Singh N; Yu VL
    Clin Infect Dis; 1992 Jan; 14(1):156-61. PubMed ID: 1571422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice.
    Saito H; Sato K; Jin BW
    Antimicrob Agents Chemother; 1984 Aug; 26(2):270-1. PubMed ID: 6592999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of bronchial ulcer due to infection by Mycobacterium abscessus].
    Kasai S; Tokuda H; Yoshikawa M; Nishiyama H
    Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):919-23. PubMed ID: 15566008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M; Rodríguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
    J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
    Thorell EA; Sharma M; Jackson MA; Selvarangan R; Woods GM
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):678-81. PubMed ID: 17023829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Swenson JM; Silcox VA; Good RC
    J Clin Microbiol; 1982 Dec; 16(6):1003-6. PubMed ID: 6298271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient].
    Prevotat A; Bonne S; Veziris N; Senneville E; Yazdanpanah Y; Legout L
    Med Mal Infect; 2011 Aug; 41(8):446-8. PubMed ID: 21435808
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycobacterium chelonei septicemia in a premature infant.
    Speert DP; Munson D; Mitchell C; Johnson DE; Thompson TR; Ferrieri P; Wannamaker LW
    J Pediatr; 1980 Apr; 96(4):681-3. PubMed ID: 7359272
    [No Abstract]   [Full Text] [Related]  

  • 38. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae.
    Prammananan T; Sander P; Brown BA; Frischkorn K; Onyi GO; Zhang Y; Böttger EC; Wallace RJ
    J Infect Dis; 1998 Jun; 177(6):1573-81. PubMed ID: 9607835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection.
    Yew WW; Kwan SY; Ma WK; Aung-khin M; Mok CK
    Chest; 1989 May; 95(5):1051-5. PubMed ID: 2707062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
    Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.